Table 2.
Disease | Vascular morphology | Blood-brain barrier | Cerebral perfusion | Selected references |
---|---|---|---|---|
Alzheimer’s disease |
|
|
|
Janelidze et al, 2017 Toledo et al., 2013 Roher et al., 2004 Montagne et al, 2015 Kisler et al., 2017a |
| ||||
Frontotemporal dementia |
|
|
|
Sudre et al., 2017 Janelidze et al., 2017 Dopper et al., 2016 Martin et al., 2001 Thal et al., 2015 |
| ||||
Amyotrophic lateral sclerosis |
|
|
|
Murphy et al., 2012 Rule et al., 2010 Abrahams et al.,1996 Henkel et al., 2009 Winkler et al., 2013 |
| ||||
Idiopathic Parkinson disease |
|
|
|
Janelidze et al., 2015 Kortekaas et al., 2005 Pisani et al., 2012 Rosengarten et al., 2010 Al-Bachari et al., 2014 Guan et al., 2013 Faucheux et al., 1999 |
| ||||
Dementia with Lewy bodies |
|
|
|
Janelidze et al., 2017 Roquet et al., 2016 Ghebremedhin et al., 2010 Miners et al., 2014 |
Abbreviations: ATS: atherosclerosis; Qalb: CSF/Plasma albumin ratio (index of BBB permeability); Gd: gadolinium; Pgp: P-glycoprotein efflux transporter; SN: substantia nigra; TJ: tight junctions; WM: white matter.